{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:09:55Z","timestamp":1767625795747},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,3,31]],"date-time":"2006-03-31T00:00:00Z","timestamp":1143763200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Tacrolimus and cyclosporine, both calcineurin inhibitors, can cause neurological side effects. While mild symptoms such as tremor are well recognised, severe complications including seizures and encephalopathy are poorly documented following renal transplantation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>We report a 42 year old man who received a cadaver renal transplant. He received tacrolimus and prednisolone. The course was uneventful for 6 weeks when he became intermittently confused, with unsteady gait and slurred speech. Following a grand mal convulsion he was admitted. He had no focal neurological signs, cerebrospinal fluid was normal; electroencephalogram was consistent with temporal lobe partial epilepsy. The magnetic resonance imaging of brain showed widespread changes with multiple areas of low signal intensity in brain stem and cerebral hemispheres. He was readmitted 3 weeks later after further fits, despite anti-convulsant therapy. He was psychotic with visual hallucinations, and rapidly became obtunded. Although his tacrolimus blood concentration had been kept in the normal range, his symptoms improved dramatically when the tacrolimus was stopped.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Severe central nervous system toxicity from calcineurin inhibitors has been rarely reported in renal transplantation and we found only one report of tacrolimus-induced toxicity in an adult. We believe the condition is frequently undiagnosed. It is a very important diagnosis not to miss as the remedy is simple and failure may result in unnecessary brain biopsy, as well as irreversible injury.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2369-7-7","type":"journal-article","created":{"date-parts":[[2006,4,19]],"date-time":"2006-04-19T12:26:39Z","timestamp":1145449599000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Progressive neurological disease induced by tacrolimus in a renal transplant recipient: Case presentation"],"prefix":"10.1186","volume":"7","author":[{"given":"Marjan","family":"Chegounchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy H","family":"Neild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,3,31]]},"reference":[{"key":"65_CR1","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1053\/jlts.2003.50181","volume":"9","author":"NR Fruhauf","year":"2003","unstructured":"Fruhauf NR, Koeppen DS, Saner FH, Egelhof DT, Stavrou G, Nadalin S, Broelsch CE: Late onset of tacrolimus-related posterior leukoencephalopathy after living donor liver transplantation. Liver Transpl. 2003, 9: 983-985. 10.1053\/jlts.2003.50181.","journal-title":"Liver Transpl"},{"key":"65_CR2","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/00007890-200002270-00001","volume":"69","author":"N Singh","year":"2000","unstructured":"Singh N, Bonham A, Fukui M: Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation. 2000, 69: 467-472. 10.1097\/00007890-200002270-00001.","journal-title":"Transplantation"},{"key":"65_CR3","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2214\/ajr.166.3.8623651","volume":"166","author":"BA Appignani","year":"1996","unstructured":"Appignani BA, Bhadelia RA, Blacklow SC, Wang AK, Roland SF, Freeman RBJ: Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity. AJR Am J Roentgenol. 1996, 166: 683-688.","journal-title":"AJR Am J Roentgenol"},{"key":"65_CR4","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJM198710013171404","volume":"317","author":"PC de Groen","year":"1987","unstructured":"de Groen PC, Aksamit AJ, Rakela J, Forbes GS, Krom RA: Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol. N Engl J Med. 1987, 317: 861-866.","journal-title":"N Engl J Med"},{"key":"65_CR5","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s004670100602","volume":"16","author":"P Parvex","year":"2001","unstructured":"Parvex P, Pinsk M, Bell LE, O'Gorman AM, Patenaude YG, Gupta IR: Reversible encephalopathy associated with tacrolimus in pediatric renal transplants. Pediatr Nephrol. 2001, 16: 537-542. 10.1007\/s004670100602.","journal-title":"Pediatr Nephrol"},{"key":"65_CR6","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1093\/ndt\/14.10.2489","volume":"14","author":"P Grimbert","year":"1999","unstructured":"Grimbert P, Azema C, Pastural M, Dhamane D, Remy P, Salomon L, Schortgen F, Baron C, Lang P: Tacrolimus (FK506)-induced severe and late encephalopathy in a renal transplant recipient. Nephrol Dial Transplant. 1999, 14: 2489-2491. 10.1093\/ndt\/14.10.2489.","journal-title":"Nephrol Dial Transplant"},{"key":"65_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1124\/mi.4.2.7","volume":"4","author":"NJ Serkova","year":"2004","unstructured":"Serkova NJ, Christians U, Benet LZ: Biochemical mechanisms of cyclosporine neurotoxicity. Mol Interv. 2004, 4: 97-107. 10.1124\/mi.4.2.7.","journal-title":"Mol Interv"},{"key":"65_CR8","first-page":"337","volume":"17","author":"O Jansen","year":"1996","unstructured":"Jansen O, Krieger D, Krieger S, Sartor K: Cortical hyperintensity on proton density-weighted images: An MR sign of cyclosporine-related encephalopathy. AJNR Am J Neuroradiol. 1996, 17: 337-344.","journal-title":"AJNR Am J Neuroradiol"},{"key":"65_CR9","first-page":"601","volume":"19","author":"WE Zimmer","year":"1998","unstructured":"Zimmer WE, Hourihane JM, Wang HZ, Schriber JR: The effect of human leukocyte antigen disparity on cyclosporine neurotoxicity after allogeneic bone marrow transplantation. AJNR Am J Neuroradiol. 1998, 19: 601-608.","journal-title":"AJNR Am J Neuroradiol"},{"key":"65_CR10","first-page":"1199","volume":"21","author":"SO Casey","year":"2000","unstructured":"Casey SO, Sampaio RC, Michel E, Truwit CL: Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. AJNR Am J Neuroradiol. 2000, 21: 1199-1206.","journal-title":"AJNR Am J Neuroradiol"},{"key":"65_CR11","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2214\/ajr.165.3.7645483","volume":"165","author":"RB Schwartz","year":"1995","unstructured":"Schwartz RB, Bravo SM, Klufas RA, Hsu L, Barnes PD, Robson CD, Antin JH: Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol. 1995, 165: 627-631.","journal-title":"AJR Am J Roentgenol"},{"key":"65_CR12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/ana.410400406","volume":"40","author":"SL Small","year":"1996","unstructured":"Small SL, Fukui MB, Bramblett GT, Eidelman BH: Immunosuppression-induced leukoencephalopathy from tacrolimus (FK506). Ann Neurol. 1996, 40: 575-580. 10.1002\/ana.410400406.","journal-title":"Ann Neurol"},{"key":"65_CR13","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1177\/088307389801300706","volume":"13","author":"JG Gleeson","year":"1998","unstructured":"Gleeson JG, duPlessis AJ, Barnes PD, Riviello JJJ: Cyclosporin A acute encephalopathy and seizure syndrome in childhood: clinical features and risk of seizure recurrence. J Child Neurol. 1998, 13: 336-344.","journal-title":"J Child Neurol"},{"key":"65_CR14","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1212\/WNL.52.7.1497","volume":"52","author":"HV Torocsik","year":"1999","unstructured":"Torocsik HV, Curless RG, Post J, Tzakis AG, Pearse L: FK506-induced leukoencephalopathy in children with organ transplants. Neurology. 1999, 52: 1497-1500.","journal-title":"Neurology"},{"key":"65_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/sj.bmt.1702143","volume":"25","author":"A Misawa","year":"2000","unstructured":"Misawa A, Takeuchi Y, Hibi S, Todo S, Imashuku S, Sawada T: FK506-induced intractable leukoencephalopathy following allogeneic bone marrow transplantation. Bone Marrow Transplant. 2000, 25: 331-334. 10.1038\/sj.bmt.1702143.","journal-title":"Bone Marrow Transplant"},{"key":"65_CR16","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/S0140-6736(84)91556-3","volume":"2","author":"CB Thompson","year":"1984","unstructured":"Thompson CB, June CH, Sullivan KM, Thomas ED: Association between cyclosporin neurotoxicity and hypomagnesaemia. Lancet. 1984, 2: 1116-1120. 10.1016\/S0140-6736(84)91556-3.","journal-title":"Lancet"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-7-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-7-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-7-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-7-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T22:14:15Z","timestamp":1630448055000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-7-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,31]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["65"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-7-7","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,31]]},"assertion":[{"value":"21 November 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"7"}}